Skip to main content Skip to navigation

Text size

Page Colour



IBSA is fully committed to the fight against doping in sport, from testing and monitoring to education and promotion. As the governing body for a range of sports, we are a signatory of the World Anti-Doping Code.

Our own anti-doping rules and regulations are therefore fully compliant with the Code, and we work closely with the World Anti-Doping Agency to ensure we are doing as much as we can to support athletes and teams to make the right choices.

You can find more information about IBSA’s work on anti-doping, including documentation and downloads, elsewhere in this section.


The spirit of sport

Doping is fundamentally contrary to the spirit of sport.

The anti-doping programme aims at preserving the intrinsic value of sport. This intrinsic value is often described as the “spirit of sport”, it is the essence of Olympism, the pursuit of human excellence through dedicated perfection of each person’s natural talents. It is how we play true. The spirit of sport is the celebration of the human spirit, body and mind and it is reflected in values we find in and through sport, including:

  • ethics, fair play and honesty
  • health
  • excellence in performance
  • character and education
  • fun and joy
  • teamwork
  • dedication and commitment
  • respect for rules and laws
  • respect for self and others
  • courage
  • community and solidarity

The principle of Strict Liability

The principle of strict liability is applied in situations where urine/blood samples collected from an athlete have produced adverse analytical results.

It means that each athlete is strictly liable for the substances found in his or her bodily specimen, and that an anti-doping rule violation occurs whenever a prohibited substance (or its metabolites or markers) is found in bodily specimen, whether or not the athlete intentionally or unintentionally used a prohibited substance or was negligent or otherwise at fault.

The principle of Strict Liability
Credit: OIS Photos

Anti-Doping Rule Violations

Anti-doping rule violations are not restricted to the use of prohibited substances and/or methods.

Apart from positive doping tests, any and all infringements below are considered to be infringements to the Anti-Doping Rules and are sanctioned by a suspension or another disciplinary sanction:

  • Presence of a prohibited substance or its metabolites or markers in an athlete’s sample
  • Use or attempted use by an athlete of a prohibited substance or a prohibited method
  • Evading, refusing or failing to submit to sample collection by an athlete
  • whereabouts failures by an athlete
  • Tampering or attempted tampering with any part of doping control by an athlete or other person
  • Possession of a prohibited substance or a prohibited method by an athlete or athlete support person
  • Trafficking or attempted trafficking in any prohibited substance or prohibited method by an athlete or other person
  • Administration or attempted administration by an athlete or other person to any athlete in-competition of any prohibited substance or prohibited method, or administration or attempted administration to any athlete out-of-competition of any prohibited substance or any prohibited method that is prohibited out of competition
  • Complicity or attempted complicity by an athlete or other person
  • Prohibited association by an athlete or other person
  • Acts by an athlete or other person to discourage or retaliate against reporting to authorities

Doping control forms (DCFs)

The World Anti-Doping Code as well as the International Standards for Testing and Investigations (ISTI) require DCFs to be submitted to WADA via ADAMS no later than 15 business days after sample collection.

Failure to do so will result in a declaration of non-compliance, in accordance with the ISO certified WADA process for non-compliance.

Anti-Doping Authorities that require assistance with the entry of the required information into ADAMS are invited to contact WADA via [email protected]

Doping control forms (DCFs)

IBSA Anti-Doping Committee

The Anti-Doping Committee oversees IBSA’s activities. It helps coordinate testing, working with the sports and ensuring education takes place throughout the year.

Should you have any questions or need further clarification, please do not hesitate to contact [email protected]

Hela Kouki Chaouachi


Juliana Soares

Education Officer

Marcelo Patrício

Tue Chair

Halim Jebali

Tue Member

Georgia Cahill

Tue Member

Henry McKinner

Tue Member

Mohy El-Din Nail

Tue Member

Caio Medauar

Legal Advisor

Annual Statistics

Since 2020, during the COVID-19 pandemic years, many IBSA sports activities were cancelled and this led to a significant decrease in anti-doping tests. Although there was a decrease in the number of tests, IBSA tried to maintain, where possible, in competition testing and orient those tests towards quality including target testing in competition and specific analysis application when affordable.

 Whereas only 20 in competition samples (including 2 blood tests) were collected in 2020 under the IBSA testing authority covering the active IBSA sports that year (Judo and Goalball within 2020 1st quarter), 2021 registered an IBSA anti-doping testing comeback under IBSA testing authorities with:

 4 doping high risk level sports tested (Judo – Powerlifting – Goalball – Blind Football)

80 tests leading to 76 urine and 4 blood samples collection (including 3 Out of competition). All IBSA competitions leading to Paralympics 2020(+1) were covered

Minimum Levels of Specific Analysis per Sport were applied to all 3 Paralympic sports tests including high risk non paralympic sports.

For the next (shortened) Paralympic cycle (2022-2024), IBSA Anti Doping staff will strengthen the input, assuring IBSA Anti-doping Testing program consistency, in terms of quantity and quality in collaboration with anti-doping stakeholders from all IBSA Member countries.

Annual Statistics

Numbers of 2022

Testing per Sport

Compared to 2021 and the years before, IBSA increased the testing scale in and out of competition upon a tough review in its Risk Assessment and Testing Distribution Plan in compliance with WADA international standards and technical documents.

During 2022 a total of 209 samples (including 2 blood samples) were collected under IBSA as Testing and Results Management Authority within the four (04) IBSA sports with the higher doping risk scores on IBSA 2022 Risk Assessment, taking also into account the number of practicing athletes and the number of sanctioned events:

OUT of competition IN competition Total Samples Up to 2022 Athletes Sanctioned events 2022 Risk score IBSA Sport
23 92 115 710 8 Medium high (17) Judo
1 10 11 230 2 Medium (13) Powerlifting
4 48 52 926 6 Medium low (12) Football
3 28 31 669 4 Medium low (12) Goalball


Testing per Gender

Upon IBSA prevails gender parity within its sports, Doping control in 2022 registered as well both genders tested out of competition and in competition at many IBSA Sanctioned events.

Samples on Women Samples on Men Total Samples Up to 2022 Athletes IBSA Sport
8 39 15 53 115 710 Judo
1 3 0 7 11 230 Powerlifting
2 6 2 42 52 926 Football
2 12 1 16 31 669 Goalball


IBSA 2022 Testing Pool (TP) included as well both genders athletes who were tested out of competition and IBSA Antidoping Committee works in tight cooperation with the different IBSA Sports Committees to update the Registered Testing Pool (RTP) for the year 2023.

Testing per Analysis

During 2022, IBSA samples were urine at 99.05% – only 2 blood samples were collected under IBSA Testing Authority.

The 207 urine samples were subject to different antidoping analysis menus depending on the:

  • type of test whether it is IN or OUT of competition
  • type of sport discipline in compliance with the TDSSA (Technical Document for Sport Specific Analysis)

The applied specific analysis on 2022 IBSA samples were as follows:

GHRFs/GH ERAs Total Samples IBSA Sport
2022 MLA* 2022 MLA*
12 (10,5%) 0,1 10 (9%) 0,1 115 Judo
4 (36 %) 0,3 1 (9 %) 0,05 11 Powerlifting
5 (9,5%) 0,05 5 (9,5%) 0,05 52 Football
2 (6 %) 0,05 2 (6 %) 0,05 31 Goalball

*: as per WADA TDSSA

With joint efforts of many stakeholders including not only IBSA but also the National Anti-Doping Organizations (NADOs) and the Local Organizing Committees (LOCs), IBSA samples met almost in all planned sports the MLA (Minimum Level for Analysis) in regard with the compulsory Specific Analysis on urine mainly ERAs (Erythropoietin Recombinant Agents) and GHRFs (Growth Hormone Releasing Factors).

Testing via Cooperation

IBSA 2022 samples were analyzed at 10 different WADA-accredited laboratories to reveal 8 Adverse Analytical Findings (AAFs) and 3 Atypical Findings (ATFs) which results management is currently ongoing.

To achieve IBSA Testing Plan for 2022, IBSA relied on the services of 12 National Anti-Doping Organizations (NADOs) from 4 continents in addition to 2 private service providers. IBSA Antidoping acknowledges the cooperation of the LOCs who made substantial efforts to meet the requested testing scale in competition.

2023 is announced as the Compliance year at IBSA Antidoping; thus all resources and procedures are being implemented with the World anti-Doping Agency (WADA) support to grant IBSA antidoping testing full compliance with IBSA sports specificities to grant doping free IBSA sports heading the 2024 Paris Paralympic Games and beyond.

TUE in 2022

Received Approved Non-approved
7 5 2

TUE per Sport

Football Goalball Judo Bowling Athletics
1 3 1 1 1

AAF on 2022

No ADVR* In Progress
9 6
Female Male
6 8
Judo Goalball Football Powerlifting Other sports
7 4 1 0 2

*The majority of AAF- Non ADVR were attested by Dorzolamida

ATF on 2022

Football Goalball Judo
1 1 1


The other IBSA sports didn’t have any major competitions in 2022.

Numbers of 2022

Communication on Privacy and Protection of Personal Information collected under IBSA Anti-Doping Program

International Blind Sport Association (IBSA) informs all partners and parties involved in the Anti-Doping Program (including IBSA athletes and their entourage) that its practices and procedures comply with international applicable rules on data privacy, including the International Standard for the Protection of Privacy and Personal Information.

IBSA, being an international para-sport federation, and thus the Anti-Doping Organization (ADO) in charge of fight against doping in blind and visually impaired para-sports, is liable, in the light of its missions, to collect personal information of various types (demographic, medical, regulatory information, etc…).

As part of its Compliance Program with the World Anti-doping Code, IBSA Anti-doping Committee undertakes to:

  • Collect only personal data necessary for work procedures, as per applicable international standards including the International Standard for Testing and Investigations
  • Use personal data only for the processing of applications or the needs of files related to the fight against doping, and share it only on a need-to-know basis
  • Keep records only for the duration of the period when this is necessary as per the applicable regulations
  • Share copies or versions only with the anti-doping or legally concerned staffs, including those of the World Anti-Doping Agency (WADA), Anti-Doping Organizations (ADOs) in other countries where the Participant could attend competitions, train or travel;
  • Disclose publicly information collected within the IBSA Anti-Doping Program only if authorized by applicable regulations
  • Respect the Participant’s rights related to personal information privacy as set out in the International Standards, including his right to file a claim,
  • Ensure the confidential and fair treatment of personal data collected under the Anti-Doping Program, without discrimination of any kind.